End of Suffering Act of 2015

Bill: 114-s-2204
Sponsor: full_name: Sen. Boxer, Barbara [D-CA]
Introduced: 2015-10-22
Policy area: Health
Subjects: Civil actions and liability

Criminal investigation, prosecution, interrogation

Drug therapy

Health personnel

Long-term, rehabilitative, and terminal care

Medical ethics
Latest action: action_date: 2015-10-22
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2015-10-22
action_desc: Introduced in Senate
text: <p><b>End of Suffering Act of 2015</b></p> <p>This bill prohibits any federal or state law, regulation, or agency action from restricting the right of a mentally competent adult who is suffering from an advanced illness with intolerable pain or a terminal illness to receive pain relief treatment from a physician.</p> A physician who treats such an individual is not subject to criminal or civil prosecution or professional disciplinary action if the physician obtains the written informed consent of the patient through a form that must be developed by the Department of Health and Human Services.

tv_txt: II 114th CONGRESS 1st Session S. 2204 IN THE SENATE OF THE UNITED STATES October 22, 2015 Mrs. Boxer introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To respect the Constitutional entitlement to liberty by recognizing the right of an individual to have personal control over the medical assistance and treatment necessary to alleviate intolerable physical suffering.

1. Short title This Act may be cited as the End of Suffering Act of 2015 . 2. Ensuring personal control over medical assistance and treatment (a) In general No Federal or State law, regulation, or agency action shall restrict the right of an adult who is suffering from an advanced illness with intolerable pain or a medically certified terminal illness, to receive medication or treatment from a physician for the relief of pain and other symptoms that limit activities of daily living. (b) Limitation on liability A physician who treats an individual described in subsection (a) with a medication or treatment sufficient to control pain and other symptoms of the illness involved shall not be subject to criminal or civil prosecution or professional disciplinary action if the physician obtains the informed consent of the patient in accordance with section 3 as provided for by the Secretary. (c) Rule of construction Nothing in this Act shall be construed to permit an individual to receive medication or treatment under subsection (a) based solely on the age or disability of the individual. 3. Informed consent Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services shall develop a written informed consent form that shall document the patient’s informed decision and be signed and dated by the patient, and witnessed by at least two individuals, for use under this Act, and issue guidance on situations where the use of such form is required. 4. Definitions In this Act: (1) Adult The term adult means a mentally competent individual who has attained the legal age for consent to medications or treatments described in section 2(a), under the applicable law of the jurisdiction in which the medication or treatment will be received, as long as that age is at least 18 years of age. (2) Advanced illness with intolerable pain The term advanced illness with intolerable pain occurs when pain associated with one or more incurable and life-threatening conditions becomes intolerable enough that general health and functioning decline, treatment begins to lose its effect, and quality of life increasingly becomes the focus of care, a process that continues to the end of life. (3) Informed decision The term informed decision means a decision by an adult, to receive a medication described in section 3, that is based on an appreciation of the relevant facts and after being fully informed by a physician of— (A) his or her medical diagnosis; (B) his or her prognosis; (C) the potential risks associated with taking the medication to be prescribed; and (D) the feasible alternatives.